Active Ingredient(s):Fospropofol Disodium FDA Approved: * December 12, 2008 Pharm Company: *EISAI MEDCL RES Category:Intravenous (IV) Therapy
Fospropofol (INN), often used as the disodium salt (trade name Lusedra) is an intravenous sedative-hypnotic agent. It is currently approved for use in sedation of adult patients undergoing diagnostic or therapeutic procedures such as endoscopy.
1 Clinical applications
2 Clinical pharmacology
2.1 Mechanism of action
3 Controlled substance
Several water-soluble ...
* May have multiple approval dates, manufacturers, or labelers. 1 Discussion